C. Mark Mckenna

Affiliations

  • at Newamsterdam Pharma Co N.v. (NAMS), 2024-07-19
  • at Perceptive Capital Solutions Corp (PCSC), 2024-06-11
  • Director at Apogee Therapeutics Inc. (APGE), 2024-06-08
  • Director at Helix Acquisition Corp. Ii (HLXB), 2024-02-09
  • at Spyre Therapeutics Inc. (SYRE), 2024-02-05
  • Chairman, President And Ceo at Prometheus Biosciences Inc. (RXDX), 2023-06-16
  • President, Salix at Bausch Health Companies Inc. (BHC), 2019-08-21
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RXDX $116.14 25,000 Officer, Director 55,144 2023-03-15 Filing
RXDX $125.13 10,620 Officer, Director 55,144 2023-03-03 Filing
RXDX $125.26 700 Officer, Director 55,144 2023-03-01 Filing
RXDX $125.10 13,680 Officer, Director 55,144 2023-02-17 Filing
RXDX $119.87 25,000 Officer, Director 55,144 2023-02-16 Filing